
Angelalign Technology Inc.
6699.HKHKSEHealthcareMedical - Instruments & Supplies
Latest quote
HK$88.10
−HK$2.80 · -3.08%
6699.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteAngelalign Technology Inc. functions as an investment holding enterprise primarily dedicated to the innovation, production, and distribution of clear aligner solutions for orthodontic treatment throughout China. Their key offerings, Angel Aligner Pro and Angel Aligner Classic, are bespoke, removable clear aligners designed to gradually guide a patient's teeth into proper alignment over time. Beyond aligner development, the company also operates dental clinics that provide a variety of services, including orthodontics and cosmetic dentistry, and distributes intraoral scanners. Their extensive portfolio of clear aligner brands features Angelalign, Angelalign Pro, Angelalign Kid, and COMFOS. The firm was founded in 2003 and maintains its principal offices in Shanghai, China.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Jiezhang Hu
- Listed since
- Jun 16, 2021
- Employees
- 4,312
Market position
Day range
Current HK$88.10
52-week range
Current HK$88.10
- Open
- HK$90.40
- Previous close
- HK$90.90
- Volume
- 540.12K
- 0.78× average
- Average volume
- 695.15K
- Average daily volume
- Market cap
- 15.12B HKD
- Beta
- 1.22
- Market reference 1
- 50-day average
- HK$79.455
- +10.88% above average
- 200-day average
- HK$73.7983
- +19.38% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 8.27B CNY
- P/E (TTM)
- 62.93×
- P/B (TTM)
- 3.73×
- P/S (TTM)
- 4.91×
- EV / EBITDA
- 28.21×
- Earnings yield
- 2.20%
- Free cash flow yield
- 5.78%
- Dividend yield
- 6.73%
Profitability & efficiency
- Gross margin
- 62.89%
- Operating margin
- 8.26%
- Net margin
- 7.69%
- Return on equity
- 5.70%
- Return on assets
- 3.73%
- Return on invested capital
- 3.22%
Financial health
- Debt / equity
- 0×
- Current ratio
- 2.98×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.59B CNY | 1.96B CNY | 1.48B CNY | 1.27B CNY | 1.27B CNY |
| Cost of goods sold | 990.95M CNY | 733.98M CNY | 555.25M CNY | 484.02M CNY | 445.03M CNY |
| Gross profit | 1.6B CNY | 1.23B CNY | 920.71M CNY | 785.69M CNY | 826.65M CNY |
| Research and development | 188.64M CNY | 155.64M CNY | 173.61M CNY | 147.68M CNY | 123.09M CNY |
| Selling, general, and administrative | 173.61M CNY | 1.1B CNY | 772.74M CNY | 483.2M CNY | 419.7M CNY |
| Operating expenses | 1.44B CNY | 1.18B CNY | 947.67M CNY | 574.37M CNY | 508.37M CNY |
| Interest income | 95.47M CNY | 15.25M CNY | 114.1M CNY | 42.29M CNY | 16.89M CNY |
| Interest expense | 12.21M CNY | 1.54M CNY | 8.02M CNY | 1.68M CNY | 1.23M CNY |
| Depreciation and amortization | 129.03M CNY | 80.27M CNY | 85.22M CNY | 65.23M CNY | 39.16M CNY |
| Operating income | 163.3M CNY | 45.85M CNY | −26.96M CNY | 211.32M CNY | 318.27M CNY |
| Net income | 199.13M CNY | 88.42M CNY | 53.48M CNY | 213.78M CNY | 285.85M CNY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 43%
- 3 beats, 2 misses, 2 met estimates
- Average EPS surprise
- -4.37%
- 7 comparable reports
- Latest EPS result
- 0.59
- Estimate 0.59 · Met by 0.00%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
6699.HK peers
ETFs holding 6699.HK
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core MSCI Emerging Markets ETFIEMG10.09M0.01%160B USD0.09%$80.245-1.62%
Vanguard Total International Stock ETFVXUS8.61M0.00%646.2B USD0.05%$87.01-0.80%
Vanguard FTSE Emerging Markets ETFVWO8.13M0.00%162.3B USD0.06%$59.845-1.00%
Vanguard FTSE All-World ex-US ETFVEU1.45M0.00%95.9B USD0.04%$85.005-0.80%
Schwab Emerging Markets Equity ETFSCHE1.06M0.01%12.89B USD0.06%$36.605-0.99%
Dimensional - Emerging Core Equity Market ETFDFAE693.32K0.01%10B USD0.29%$38.88-1.54%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM651.58K0.01%9.49B USD0.39%$39.385-1.36%
Vanguard Total World Stock ETFVT524.96K0.00%97.9B USD0.06%$159.9-0.54%
iShares Core MSCI Emerging Markets ETFIEMG- Market value
- 10.09M
- Weight
- 0.01%
- AUM
- 160B USD
- Expense ratio
- 0.09%
- Price / 1D
- $80.245-1.62%
Vanguard Total International Stock ETFVXUS- Market value
- 8.61M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.01-0.80%
Vanguard FTSE Emerging Markets ETFVWO- Market value
- 8.13M
- Weight
- 0.00%
- AUM
- 162.3B USD
- Expense ratio
- 0.06%
- Price / 1D
- $59.845-1.00%
Vanguard FTSE All-World ex-US ETFVEU- Market value
- 1.45M
- Weight
- 0.00%
- AUM
- 95.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $85.005-0.80%
Schwab Emerging Markets Equity ETFSCHE- Market value
- 1.06M
- Weight
- 0.01%
- AUM
- 12.89B USD
- Expense ratio
- 0.06%
- Price / 1D
- $36.605-0.99%
Dimensional - Emerging Core Equity Market ETFDFAE- Market value
- 693.32K
- Weight
- 0.01%
- AUM
- 10B USD
- Expense ratio
- 0.29%
- Price / 1D
- $38.88-1.54%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM- Market value
- 651.58K
- Weight
- 0.01%
- AUM
- 9.49B USD
- Expense ratio
- 0.39%
- Price / 1D
- $39.385-1.36%
Vanguard Total World Stock ETFVT- Market value
- 524.96K
- Weight
- 0.00%
- AUM
- 97.9B USD
- Expense ratio
- 0.06%
- Price / 1D
- $159.9-0.54%
Continue in GoAI
Research 6699.HKresearch.disclaimer





